Community Brain Health Program to Lower Dementia Risk for older adults
Official title: Community-based Brain Health Program to Reduce Dementia Risk-BHP
Funded at Posit Science Corporation · NIH-11407547 · Data updated 2026-11-12
A community-based program aimed at reducing dementia risk in adults 65 and older is being tested through a large, practical trial in YMCA settings.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Posit Science Corporation NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | September 22, 2026 |
| Project end | May 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $1,232,307 |
| NIH project number | 1R44AG099297-01A1 |
| Project ID | NIH-11407547 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults aged 65 and older who are at risk for dementia, especially those with or at risk for adult-onset diabetes mellitus.
✕Less likely to help
Some participants may not experience noticeable cognitive or functional benefits during the study period.
What this research studies
This project tests a Brain Health Program delivered in communities to help older adults eat better, exercise, and stay mentally sharp. Participants are randomly assigned to the Brain Health Program or to receiving standard health education materials. The goal is to see if the program can reduce dementia risk and help maintain daily independence and cognitive skills. It takes place in real-world community centers, making it easier for older adults to participate. If successful, it could be scaled to reach many people through community networks like the YMCA.
Why it matters
Potential benefit: If successful, the program could lower dementia risk and help older adults stay independent longer.
How similar studies have gone: Similar multimodal lifestyle programs have shown potential benefits, but this trial aims to confirm impact in a large, real-world setting.
Where this research is happening
-
Posit Science Corporation
San Francisco, United States Active
Researchers
- Principal investigator: Vanvleet, Tom — Posit Science Corporation
- Study coordinator: Vanvleet, Tom
Related research
Other NIH-funded projects on the same topics.
-
Investigating how DNA damage and repair mechanisms are altered in ALS and frontotemporal dementia.
This study is looking at how problems with DNA repair might contribute to conditions like ALS and frontotemporal dementia, and it’s testing ways to fix these issues in cells from patients to help develop new treatments.
-
Synthetic protein mimetics to treat Lewy Body Dementia
A new therapeutic approach using engineered protein-like molecules to block the harmful protein clumps that cause Lewy Body Dementia.
-
Dementia care staff study: adapting a US survey for use in many countries
A study is adapting and testing a survey for dementia care workers in the US, Brazil, Switzerland, and Ghana to help understand why workers stay in their jobs and how to improve care.
-
Dementia care staff study: adapting a survey for use in many countries
A multinational study will adapt and test a U.S. dementia-care worker survey in Brazil, Switzerland, and Ghana to help understand why staff stay in or leave long-term care settings.
-
Study of Dementia Care Staff in 4 Countries: Adapting Caregiver Surveys Across Cultures
A multinational project will adapt and test a dementia care worker survey so researchers can compare care environments across the US, Brazil, Switzerland, and Ghana.
-
New biomarkers to distinguish LATE from Alzheimer’s disease in dementia
A study to develop blood and CSF tests that can tell apart LATE from Alzheimer’s disease in people with dementia.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.